Aurinia Pharmaceuticals (AUPH) Change in Account Payables (2024 - 2026)

Aurinia Pharmaceuticals (AUPH) has 3 years of Change in Account Payables data on file, last reported at -$652000.0 in Q1 2026.

• Quarterly Change in Account Payables rose 33.06% year-over-year to -$652000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.6 million (down 6.37% YoY) and the FY2025 annual result came in at -$1.9 million, down 317.91% from the prior year.
• Change in Account Payables retreated to -$652000.0 in Q1 2026, from $1.1 million in the prior quarter.
• In the past five years, Change in Account Payables ranged from a high of $2.7 million in Q2 2024 to a low of -$3.7 million in Q4 2024.
• A 3-year average of -$185111.1 and a median of -$652000.0 in 2026 frame the typical range for Change in Account Payables.
• The widest YoY moves for Change in Account Payables: up 129.78% in 2025, down 337.15% in 2025.
• Tracing AUPH's Change in Account Payables over 3 years: stood at -$3.7 million in 2024, then soared by 129.78% to $1.1 million in 2025, then tumbled by 159.33% to -$652000.0 in 2026.
• The last three Change in Account Payables figures came in at -$652000.0 (Q1 2026), $1.1 million (Q4 2025), and -$1.1 million (Q3 2025), per Business Quant data.